DCDC Health Services, which operates under the DCDC Kidney Care brand, has received a ₹150 crore investment from Singapore-based ABC Impact, an Asia-focused impact investor supported by Temasek.
Expanding Reach Across India
DCDC currently operates over 200 dialysis centers across India through public-private partnerships (PPP) and standalone clinics, serving over 20,000 patients annually. The newly secured funding will enable the launch of 150+ new clinics, significantly expanding access to life-saving dialysis treatments.
Addressing India’s Dialysis Challenges
With over 1.5 million people in India suffering from end-stage renal disease, there is an urgent need for affordable and accessible dialysis care. Many patients struggle with high costs, lack of facilities, and inconsistent care quality, particularly affecting low-income families. DCDC currently performs 100,000 dialysis sessions per month, primarily serving economically weaker sections.
Global Expansion on the Horizon
DCDC’s founder and CEO, Aseem Garg, stated that the company is also exploring opportunities beyond India, aiming to extend its solutions internationally.
Investor Support for Lifesaving Treatment
Sugandhi Matta, Chief Impact Officer at ABC Impact, highlighted that enhancing dialysis access is both a healthcare and economic necessity in India. The investment will help bring treatment closer to patients, reducing financial and logistical burdens.
Strong Backing from Global Investors
DCDC’s existing investors include the Danish government-owned IFU and the Asian Development Bank (ADB). IFU’s investment is part of the Danish SDG Investment Fund, backed by the Danish State and private institutional investors.
With this funding, DCDC is set to revolutionize kidney care in India, improving access to dialysis and supporting thousands of patients in need.
